الوصف

Sphingolipid profiling by mass spectrometry reveals the specific ceramide species most affected by Cordyceps treatment, providing insight into the selectivity of SPT inhibition.

Figure 10

Chart

Source Paper

Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis.

Scientific reports (2022)

PMID: 35508667

DOI: 10.1038/s41598-022-11219-3

Cite This Figure

![Figure 10: Sphingolipid profiling by mass spectrometry reveals the specific ceramide species most affected by Cordyceps treatment, providing insight into the selectivity of SPT inhibition.]()

> Source: Ying Li et al. "Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hep." *Scientific reports*, 2022. PMID: [35508667](https://pubmed.ncbi.nlm.nih.gov/35508667/)

<figure>
  <img src="" alt="Sphingolipid profiling by mass spectrometry reveals the specific ceramide species most affected by Cordyceps treatment, providing insight into the selectivity of SPT inhibition." />
  <figcaption>Figure 10. Sphingolipid profiling by mass spectrometry reveals the specific ceramide species most affected by Cordyceps treatment, providing insight into the selectivity of SPT inhibition.<br>  Source: Ying Li et al. "Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hep." <em>Scientific reports</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35508667/">35508667</a></figcaption>
</figure>

أدلة ذات صلة

CLA لـ Obesity

التقييم B · 18 دراسات